These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 1651078

  • 1. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE, Chow A, Drapeau G.
    Biochem Pharmacol; 1991 Jul 25; 42(4):721-7. PubMed ID: 1651078
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N.
    Drapeau G, Chow A, Ward PE.
    Peptides; 1991 Jul 25; 12(3):631-8. PubMed ID: 1656406
    [Abstract] [Full Text] [Related]

  • 3. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P.
    Ahmad S, Ward PE.
    Proc Soc Exp Biol Med; 1992 May 25; 200(1):115-21. PubMed ID: 1315058
    [Abstract] [Full Text] [Related]

  • 4. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK, Dawson LG, Hall JM.
    Br J Pharmacol; 1995 Feb 25; 114(3):612-7. PubMed ID: 7735687
    [Abstract] [Full Text] [Related]

  • 5. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G, deBlois D, Marceau F.
    J Pharmacol Exp Ther; 1991 Dec 25; 259(3):997-1003. PubMed ID: 1662280
    [Abstract] [Full Text] [Related]

  • 6. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M, Jin HY, Katori M, Sunahara N.
    Agents Actions Suppl; 1992 Dec 25; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [Abstract] [Full Text] [Related]

  • 7. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S, Lecci A, Maggi CA.
    Br J Pharmacol; 1996 Apr 25; 117(8):1619-24. PubMed ID: 8732268
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological and functional characterization of bradykinin receptors in canine cultured tracheal epithelial cells.
    Luo SF, Tsai CT, Wu WB, Pan SL, Tsai YJ, Yang CM.
    Br J Pharmacol; 1996 Sep 25; 119(2):439-45. PubMed ID: 8886432
    [Abstract] [Full Text] [Related]

  • 9. Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: involvement of B1 and B2 receptors.
    Gouin L, Cardinal R, Adam A, Drapeau G, Nadeau R.
    J Cardiovasc Pharmacol; 1996 Aug 25; 28(2):337-43. PubMed ID: 8856493
    [Abstract] [Full Text] [Related]

  • 10. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    Drapeau G, Audet R, Levesque L, Godin D, Marceau F.
    J Pharmacol Exp Ther; 1993 Jul 25; 266(1):192-9. PubMed ID: 8392550
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
    Tousignant C, Regoli D, Rhaleb NE, Jukic D, Guillemette G.
    Eur J Pharmacol; 1992 Mar 12; 225(3):235-44. PubMed ID: 1325366
    [Abstract] [Full Text] [Related]

  • 12. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
    Tropea MM, Gummelt D, Herzig MS, Leeb-Lundberg LM.
    J Pharmacol Exp Ther; 1993 Feb 12; 264(2):930-7. PubMed ID: 8382284
    [Abstract] [Full Text] [Related]

  • 13. Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay--a useful parameter of plasma kinin release.
    Majima M, Ueno A, Sunahara N, Katori M.
    Adv Exp Med Biol; 1989 Feb 12; 247B():331-5. PubMed ID: 2692413
    [No Abstract] [Full Text] [Related]

  • 14. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels.
    Regoli D, Drapeau G, Rovero P, Dion S, Rhaleb NE, Barabé J, D'Orléans-Juste P, Ward P.
    Eur J Pharmacol; 1986 Aug 15; 127(3):219-24. PubMed ID: 2875891
    [Abstract] [Full Text] [Related]

  • 15. Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase.
    Palmieri FE, Bausback HH, Churchill L, Ward PE.
    Biochem Pharmacol; 1986 Aug 15; 35(16):2749-56. PubMed ID: 3091032
    [Abstract] [Full Text] [Related]

  • 16. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P.
    Blais C, Marc-Aurèle J, Simmons WH, Loute G, Thibault P, Skidgel RA, Adam A.
    Peptides; 1999 Aug 15; 20(4):421-30. PubMed ID: 10458510
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.
    Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO.
    Am J Physiol Heart Circ Physiol; 2000 Apr 15; 278(4):H1069-74. PubMed ID: 10749699
    [Abstract] [Full Text] [Related]

  • 18. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.
    Proud D, Baumgarten CR, Naclerio RM, Ward PE.
    J Immunol; 1987 Jan 15; 138(2):428-34. PubMed ID: 2878955
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM, Calixto JB.
    Br J Pharmacol; 1998 Jan 15; 123(2):281-91. PubMed ID: 9489617
    [Abstract] [Full Text] [Related]

  • 20. Structural requirements for B2-agonists with improved degradation stability.
    Dendorfer A, Wagemann M, Reissmann S, Dominiak P.
    Immunopharmacology; 1999 Dec 15; 45(1-3):199-205. PubMed ID: 10615012
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.